3D genome contributes to MHC-II neoantigen prediction.

Area of Science:

• Genomics
• Immunology
• Bioinformatics

Background:

• High-throughput sequencing enables neoantigen identification for cancer immunotherapy.
• Predicting Human Leukocyte Antigen (HLA)-II presented neoantigens is challenging due to peptide variability and complex genetics.
• Current computational methods overlook the role of the 3D genome in neoantigen prediction.

Purpose of the Study:

• To investigate the influence of 3D genome architecture on the origin of HLA-II neoantigens.
• To enhance the accuracy of HLA-II neoantigen prediction by integrating 3D genome information.

Main Methods:

• Analysis of DNA and RNA sequencing data from cancer patients.
• Investigation of neoantigen origins within the context of 3D genome structure.
• Development and evaluation of computational approaches incorporating 3D genome data.

Main Results:

• The 3D chromatin architecture significantly impacts the identification of immune-positive and non-negative HLA-II neoantigens.
• Integration of 3D genome information improves the precision of HLA-II neoantigen prediction.

Conclusions:

• 3D genome architecture is a crucial factor for accurate HLA-II neoantigen discovery.
• Incorporating 3D genome data holds promise for advancing precision and personalized cancer immunotherapy.